S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Biogen (BIIB) Earnings Date, Estimates & Call Transcripts

$194.38
+3.86 (+2.03%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 24
Before Market Opens
Confirmed
Actual EPS
(Feb. 13)
$2.95 Missed By -$0.23
Consensus EPS
(Feb. 13)
$3.18
Skip Charts & View Estimated and Actual Earnings Data

BIIB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIIB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Biogen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$3.25$3.54$3.34 
Q2 20244$3.53$4.11$3.89 
Q3 20244$3.64$4.18$4.03 
Q4 20244$3.77$4.11$3.93 
FY 202416$14.19$15.94$15.18 
Q1 20252$3.59$4.46$4.03 
Q2 20252$4.18$4.67$4.43 
Q3 20252$4.44$4.88$4.66 
Q4 20252$4.58$4.83$4.71 
FY 20258$16.79$18.84$17.82 
Q1 20261$3.95$3.95$3.95 

BIIB Earnings Date and Information

Biogen last announced its earnings results on February 13th, 2024. The biotechnology company reported $2.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.18 by $0.23. The firm earned $2.39 billion during the quarter, compared to analyst estimates of $2.47 billion. Biogen has generated $7.98 earnings per share over the last year ($7.98 diluted earnings per share) and currently has a price-to-earnings ratio of 24.4. Earnings for Biogen are expected to grow by 13.18% in the coming year, from $15.48 to $17.52 per share. Biogen has confirmed that its next quarterly earnings report will be published on Wednesday, April 24th, 2024. Biogen will be holding an earnings conference call on Wednesday, April 24th at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Biogen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/24/2024
Confirmed)
-------  
2/13/2024Q4 2023$3.18$2.95($0.23)$4.19$2.47 billion$2.39 billion    
11/8/2023Q3 2023$3.99$4.36+$0.37$9.19$2.40 billion$2.53 billion    
7/25/2023Q2 2023$3.77$4.02+$0.25$3.97$2.36 billion$2.46 billion    
4/25/2023Q1 2023$3.25$3.40+$0.15$4.13$2.34 billion$2.46 billion      
2/15/2023Q4 2022$3.48$4.05+$0.57$4.31$2.44 billion$2.54 billion    
10/25/2022Q3 2022$4.13$4.77+$0.64$1.70$2.47 billion$2.51 billion      
7/20/2022Q2 2022$4.09$5.25+$1.16$3.26$2.48 billion$2.59 billion      
5/3/2022Q1 2022$4.41$3.62($0.79)$5.18$2.50 billion$2.53 billion    
2/3/2022Q4 2021$3.32$3.39+$0.07$4.28$2.62 billion$2.73 billion    
10/19/2021Q3 2021$4.09$4.77+$0.68$7.32$2.67 billion$2.78 billion    
7/21/2021Q2 2021$4.55$5.68+$1.13$8.37$2.61 billion$2.78 billion    
4/21/2021Q1 2021$5.06$5.34+$0.28$7.99$2.67 billion$2.69 billion    

Biogen Earnings - Frequently Asked Questions

When is Biogen's earnings date?

Biogen has confirmed that its next quarterly earnings data will be published on Wednesday, April 24th, 2024. Learn more on BIIB's earnings history.

Did Biogen beat their earnings estimates last quarter?

In the previous quarter, Biogen (NASDAQ:BIIB) missed the analysts' consensus estimate of $3.18 by $0.23 with a reported earnings per share (EPS) of $2.95. Learn more on analysts' earnings estimate vs. BIIB's actual earnings.

How can I listen to Biogen's earnings conference call?

The conference call for Biogen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Biogen's conference call transcript?

The conference call transcript for Biogen's latest earnings report can be read online. Read Transcript

How much revenue does Biogen generate each year?

Biogen (NASDAQ:BIIB) has a recorded annual revenue of $9.84 billion.

How much profit does Biogen generate each year?

Biogen (NASDAQ:BIIB) has a recorded net income of $1.16 billion. BIIB has generated $7.98 earnings per share over the last four quarters.

What is Biogen's price-to-earnings ratio?

Biogen (NASDAQ:BIIB) has a trailing price-to-earnings ratio of 24.36 and a forward price-to-earnings ratio of 12.56. The price/earnings-to-growth ratio is 1.83.

What is Biogen's EPS forecast for next year?

Biogen's earnings are expected to grow from $15.48 per share to $17.52 per share in the next year, which is a 13.18% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:BIIB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners